These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16524540)

  • 1. Imaging cardiac neuronal function and dysfunction.
    Higuchi T; Schwaiger M
    Curr Cardiol Rep; 2006 Mar; 8(2):131-8. PubMed ID: 16524540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cardiac sympathetic neuronal function using PET imaging.
    Bengel FM; Schwaiger M
    J Nucl Cardiol; 2004; 11(5):603-16. PubMed ID: 15472645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET and SPET tracers for mapping the cardiac nervous system.
    Langer O; Halldin C
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):416-34. PubMed ID: 12002720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cardiac autonomic neuronal function using PET imaging.
    Thackeray JT; Bengel FM
    J Nucl Cardiol; 2013 Feb; 20(1):150-65. PubMed ID: 23179458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting neuronal dysfunction and receptor imaging.
    Camacho V; Carrió I
    Curr Opin Biotechnol; 2007 Feb; 18(1):60-4. PubMed ID: 17223339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
    Langer A; Freeman MR; Josse RG; Armstrong PW
    J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic cardiac autonomic dysfunction: parasympathetic versus sympathetic.
    Uehara A; Kurata C; Sugi T; Mikami T; Shouda S
    Ann Nucl Med; 1999 Apr; 13(2):95-100. PubMed ID: 10355953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical role of positron emission tomography in management of the cardiac patient.
    Pirich C; Schwaiger M
    Rev Port Cardiol; 2000 Feb; 19 Suppl 1():I89-100. PubMed ID: 10750444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic evaluation of cardiac autonomic innervation.
    Münch G; Ziegler S; Nguyen N; Hartmann F; Watzlowik P; Schwaiger M
    J Nucl Cardiol; 1996; 3(3):265-77. PubMed ID: 8805746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of cardiac sympathetic imaging in heart failure.
    Christensen TE; Kjaer A; Hasbak P
    Clin Physiol Funct Imaging; 2014 May; 34(3):178-82. PubMed ID: 24138454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in nuclear cardiology: new imaging beyond perfusion and function].
    Tamaki N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):656-62. PubMed ID: 10565167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sympathetic neuronal imaging using PET.
    Lautamäki R; Tipre D; Bengel FM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S74-85. PubMed ID: 17479262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
    Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
    Gupta S; Amanullah A
    Heart Fail Rev; 2015 Mar; 20(2):215-26. PubMed ID: 25135163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of metaiodobenzylguanidine imaging in cardiology.
    Merlet P; Piot O; Dubois-Randé JL; Loisance D; Castaigne A; Syrota A
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):29-39. PubMed ID: 9002746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry and biology of radiotracers that target changes in sympathetic and parasympathetic nervous systems in heart disease.
    Eckelman WC; Dilsizian V
    J Nucl Med; 2015 Jun; 56 Suppl 4():7S-10S. PubMed ID: 26033907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nuclear medicine technique in evaluating electrophysiology in diabetic hearts especially with 123I-MIBG cardiac SPECT imaging.
    Flotats A; Carrió I
    Minerva Endocrinol; 2009 Sep; 34(3):263-71. PubMed ID: 19859048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography.
    Allman KC; Stevens MJ; Wieland DM; Hutchins GD; Wolfe ER; Greene DA; Schwaiger M
    J Am Coll Cardiol; 1993 Nov; 22(5):1425-32. PubMed ID: 8227801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac neurotransmission SPECT imaging.
    Flotats A; Carrió I
    J Nucl Cardiol; 2004; 11(5):587-602. PubMed ID: 15472644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure.
    Zelt JGE; deKemp RA; Rotstein BH; Nair GM; Narula J; Ahmadi A; Beanlands RS; Mielniczuk LM
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):1036-1054. PubMed ID: 31326479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.